TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
STAA

STAAR Surgical Company

Healthcare · Medical Instruments & Supplies

21.20$ -5.2% vs. previous close Closing price · As of: Sep 17, 2026

Ownership

Ownership Structure

Who owns STAAR Surgical Company (STAA)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 52.1% of the shares are freely tradable; institutional investors hold 113.8%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 113.8%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 0.8%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 52.1%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 17.7%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 50Mio.

Largest Shareholders

Institutions

Institutions STAA
Name Stake (%) Shares Change (%) Date
BROADWOOD CAPITAL Inc 32.16 16,123,842 +0.0 06/30/2026
BlackRock Inc 13.29 6,666,118 -9.4 03/31/2026
Yunqi Capital Ltd 6.50 3,257,130 +0.0 06/30/2026
Madison Avenue Partners, LP 4.87 2,441,678 +0.0 03/31/2026
Vanguard Portfolio Management, LLC 4.24 2,123,589 +0.0 03/31/2026
State Street Corp 3.66 1,832,996 -5.5 03/31/2026
Vanguard Capital Management, LLC 3.37 1,690,606 +0.0 03/31/2026
Anatole Investment Management Ltd 3.29 1,651,701 +3.1 06/30/2026
Morgan Stanley - Brokerage Accounts 2.99 1,499,356 +61.4 03/31/2026

Funds

Funds STAA
Name Stake (%) Shares Change (%) Date
iShares Core S&P Small-Cap ETF 6.04 3,030,110 -0.3 08/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider holdings

Insider holdings STAA
Person Role Shares Value As of Type
Foust Warren President and CEO 95,816 2,031,299 $ Aug 14, 2026 direct
Michna Magda Chief Development Officer 41,343 876,472 $ Aug 14, 2026 direct
Andrews Deborah J Chief Financial Officer & EVP 38,910 824,892 $ Aug 14, 2026 direct

Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.

Insiders

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
Aug 14, 2026 Foust Warren President and CEO Other 1,865 26.18 48,826
Aug 14, 2026 Foust Warren President and CEO Other 3,666 0.00
Aug 14, 2026 Foust Warren President and CEO Other 3,730 26.18 97,651
Aug 14, 2026 Foust Warren President and CEO Other 7,331 0.00
Aug 14, 2026 Michna Magda Chief Development Officer Other 1,100 26.18 28,798
Aug 14, 2026 Michna Magda Chief Development Officer Other 559 26.18 14,635
Aug 14, 2026 Michna Magda Chief Development Officer Other 2,797 26.18 73,225
Aug 14, 2026 Michna Magda Chief Development Officer Other 5,499 0.00
Aug 14, 2026 Andrews Deborah J Chief Financial Officer & EVP Other 2,662 26.18 69,691
Aug 14, 2026 Andrews Deborah J Chief Financial Officer & EVP Other 5,233 0.00
Jul 31, 2026 Foust Warren President and CEO Other 10,576 24.36 257,631
Jul 31, 2026 Foust Warren President and CEO Other 20,787
Jul 31, 2026 Andrews Deborah J Chief Financial Officer & EVP Other 10,576 24.36 257,631
Jul 31, 2026 Andrews Deborah J Chief Financial Officer & EVP Other 20,787
Jun 25, 2026 Andrews Deborah J Chief Financial Officer & EVP Other 6,480 31.21 202,241
Jun 25, 2026 Andrews Deborah J Chief Financial Officer & EVP Other 13,955

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?